6709 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Advagene Biopharma Co., Ltd. engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy. The company was founded on September 19, 2006 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
6709 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company